341 related articles for article (PubMed ID: 26666737)
1. The Association Between Neutrophil/Lymphocyte Ratio and Disease Activity in Rheumatoid Arthritis and Ankylosing Spondylitis.
Mercan R; Bitik B; Tufan A; Bozbulut UB; Atas N; Ozturk MA; Haznedaroglu S; Goker B
J Clin Lab Anal; 2016 Sep; 30(5):597-601. PubMed ID: 26666737
[TBL] [Abstract][Full Text] [Related]
2. Mean platelet volume, red cell distribution width, platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in patients with ankylosing spondylitis and their relationships with high-frequency hearing thresholds.
Bozan N; Alpaycı M; Aslan M; Cankaya H; Kıroglu AF; Turan M; Ayral A; Senkoy E; Ilter S
Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3663-3672. PubMed ID: 27034281
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil/lymphocyte and platelet/lymphocyte ratios as potential markers of disease activity in patients with Ankylosing spondylitis: a case-control study.
Al-Osami MH; Awadh NI; Khalid KB; Awadh AI
Adv Rheumatol; 2020 Jan; 60(1):13. PubMed ID: 32000859
[TBL] [Abstract][Full Text] [Related]
4. Characterization of neutrophil-to-lymphocyte ratio as a measure of inflammation in rheumatoid arthritis.
Chandrashekara S; Mukhtar Ahmad M; Renuka P; Anupama KR; Renuka K
Int J Rheum Dis; 2017 Oct; 20(10):1457-1467. PubMed ID: 28952205
[TBL] [Abstract][Full Text] [Related]
5. Relationship between neutrophil-lymphocyte, platelet-lymphocyte ratio and disease activity in rheumatoid arthritis treated with rituximab.
Sargin G; Senturk T; Yavasoglu I; Kose R
Int J Rheum Dis; 2018 Dec; 21(12):2122-2127. PubMed ID: 30338636
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Platelets-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios in Rheumatoid Arthritis and Ankylosing Spondylitis.
Khan S; Yousaf MJ; Rashid A; Manzar A
J Coll Physicians Surg Pak; 2024 Jan; 34(1):68-72. PubMed ID: 38185964
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil- and platelet-to-lymphocyte ratios are correlated with disease activity in rheumatoid arthritis.
Fu H; Qin B; Hu Z; Ma N; Yang M; Wei T; Tang Q; Huang Y; Huang F; Liang Y; Yang Z; Zhong R
Clin Lab; 2015; 61(3-4):269-73. PubMed ID: 25974992
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-Lymphocyte Ratio Connected to Treatment Options and Inflammation Markers of Ankylosing Spondylitis.
Gökmen F; Akbal A; Reşorlu H; Gökmen E; Güven M; Aras AB; Erbağ G; Kömürcü E; Akbal E; Coşar M
J Clin Lab Anal; 2015 Jul; 29(4):294-8. PubMed ID: 24849656
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil lymphocyte ratio in patients with ankylosing spondylitis: A systematic review and meta-analysis.
Xu S; Ma Y; Wu M; Zhang X; Yang J; Deng J; Guan S; Gao X; Xu S; Shuai Z; Guan S; Chen L; Pan F
Mod Rheumatol; 2020 Jan; 30(1):141-148. PubMed ID: 30605008
[No Abstract] [Full Text] [Related]
10. Neutrophil-lymphocyte and platelet-lymphocyte rate and their seasonal differences in ankylosing spondylitis and rheumatoid arthritis patients using anti-TNF medication.
Enginar AU; Kacar C
Bratisl Lek Listy; 2019; 120(8):586-592. PubMed ID: 31379182
[TBL] [Abstract][Full Text] [Related]
11. Relationship of hematologic markers with IL-17 and IL-1 beta in patients with rheumatoid arthritis.
Sağ S; Sağ MS; Tekeoğlu I; Kamanlı A; Nas K; Acar BA
J Back Musculoskelet Rehabil; 2018; 31(4):703-707. PubMed ID: 29578474
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis.
Coşkun BN; Öksüz MF; Ermurat S; Tufan AN; Oruçoğlu N; Doğan A; Dalkılıç E; Pehlivan Y
Eur J Rheumatol; 2014 Sep; 1(3):101-105. PubMed ID: 27708888
[TBL] [Abstract][Full Text] [Related]
13. M2 polarization of monocytes in ankylosing spondylitis and relationship with inflammation and structural damage.
Zhao J; Yuan W; Tao C; Sun P; Yang Z; Xu W
APMIS; 2017 Dec; 125(12):1070-1075. PubMed ID: 28971528
[TBL] [Abstract][Full Text] [Related]
14. Overlooked hematological markers of disease activity in rheumatoid arthritis.
Tekeoğlu İ; Gürol G; Harman H; Karakeçe E; Çiftçi İH
Int J Rheum Dis; 2016 Nov; 19(11):1078-1082. PubMed ID: 26620362
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-lymphocyte ratio, pain perception, and disease activity score may serve as important predictive markers for sustained remission in rheumatoid arthritis.
Chandrashekara S; Rajendran A; Bai Jaganath A; Krishnamurthy R
Reumatismo; 2015 Dec; 67(3):109-15. PubMed ID: 26876190
[TBL] [Abstract][Full Text] [Related]
16. Two new inflammatory markers associated with Disease Activity Score-28 in patients with rheumatoid arthritis: neutrophil-lymphocyte ratio and platelet-lymphocyte ratio.
Uslu AU; Küçük A; Şahin A; Ugan Y; Yılmaz R; Güngör T; Bağcacı S; Küçükşen S
Int J Rheum Dis; 2015 Sep; 18(7):731-5. PubMed ID: 25900081
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil/Lymphocyte Ratio in Patients with Rheumatoid Arthritis Treated with Biological Agents.
Koiwa M; Goto S; Takahashi K; Kamada T; Takai S; Nakamura H
J Nippon Med Sch; 2016; 83(3):118-24. PubMed ID: 27430176
[TBL] [Abstract][Full Text] [Related]
18. [Neutrophil-lymphocyte and platelet-lymphocyte ratios for assessing disease activity in patients with rheumatoid arthritis receiving tofacitinib treatment].
Tang J; Chen J; Lin G; Zhang H; Gui M; Li N; Gu Y; Luo L; Sun J
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1651-1656. PubMed ID: 37933639
[TBL] [Abstract][Full Text] [Related]
19. The neutrophil-lymphocyte ratio in early rheumatoid arthritis and its ability to predict subsequent failure of triple therapy.
Boulos D; Proudman SM; Metcalf RG; McWilliams L; Hall C; Wicks IP
Semin Arthritis Rheum; 2019 Dec; 49(3):373-376. PubMed ID: 31248587
[TBL] [Abstract][Full Text] [Related]
20. Seasonal disease activity and serum vitamin D levels in rheumatoid arthritis, ankylosing spondylitis and osteoarthritis.
Yazmalar L; Ediz L; Alpayci M; Hiz O; Toprak M; Tekeoglu I
Afr Health Sci; 2013 Mar; 13(1):47-55. PubMed ID: 23658567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
